摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-hydroxy-8-methoxy-1,9-dimethyl-11-oxo-4-[(4-sulfamoyl-phenyl)-aminomethyl]-11H-dibenzo[b,e][1,4]dioxepine-6-carboxylic acid | 1089141-71-8

中文名称
——
中文别名
——
英文名称
3-hydroxy-8-methoxy-1,9-dimethyl-11-oxo-4-[(4-sulfamoyl-phenyl)-aminomethyl]-11H-dibenzo[b,e][1,4]dioxepine-6-carboxylic acid
英文别名
9-Hydroxy-3-methoxy-4,7-dimethyl-6-oxo-10-[(4-sulfamoylanilino)methyl]benzo[b][1,4]benzodioxepine-1-carboxylic acid
3-hydroxy-8-methoxy-1,9-dimethyl-11-oxo-4-[(4-sulfamoyl-phenyl)-aminomethyl]-11H-dibenzo[b,e][1,4]dioxepine-6-carboxylic acid化学式
CAS
1089141-71-8
化学式
C24H22N2O9S
mdl
——
分子量
514.513
InChiKey
NLOJRHFRKADGJL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    36
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    183
  • 氢给体数:
    4
  • 氢受体数:
    11

文献信息

  • HEPTACYCLIC COMPOUNDS AND THE PHARMACEUTICAL USES THEREOF FOR PREVENTING AND TREATING DIABETES AND METABOLIC SYNDROME
    申请人:Shen Jianhua
    公开号:US20100173905A1
    公开(公告)日:2010-07-08
    The invention discloses a new use of a class of heptacyclic compounds in the preparation of formulations for the prevention and treatment of diabetes and metabolic syndromes; the present invention also discloses a new class of heptacyclic compounds; the present invention also discloses a process for preparing the heptacyclic compounds and a composition containing the same. The heptacyclic compounds of the present invention can be used to effectively preventing or treating diseases such as diabetes and metabolic syndromes.
    本发明公开了一类七环化合物在制备用于预防和治疗糖尿病和代谢综合症的配方中的新用途;本发明还公开了一类新的七环化合物;本发明还公开了一种制备七环化合物和含有七环化合物的组成物的方法。本发明的七环化合物可用于有效地预防或治疗糖尿病和代谢综合症等疾病。
  • COMPOUNDS WITH 7-MEMBER CYCLE AND THE PHARMACEUTICAL USE THEREOF FOR PREVENTING AND TREATING DIABETES AND METABOLISM SYNDROME
    申请人:Shanghai Institute of Materia Medica, Chinese Academy of Sciences
    公开号:EP2199295A1
    公开(公告)日:2010-06-23
    The invention discloses a new use of a class of heptacyclic compounds in the preparation of formulations for the prevention and treatment of diabetes and metabolic syndromes; the present invention also discloses a new class of heptacyclic compounds; the present invention also discloses a process for preparing the heptacyclic compounds and a composition containing the same. The heptacyclic compounds of the present invention can be used to effectively preventing or treating diseases such as diabetes and metabolic syndromes.
    本发明公开了一类庚环化合物在制备预防和治疗糖尿病和代谢综合征的制剂中的新用途;本发明还公开了一类新的庚环化合物;本发明还公开了制备庚环化合物和含有庚环化合物的组合物的工艺。本发明的庚环化合物可用于有效预防或治疗糖尿病和代谢综合征等疾病。
  • US8158623B2
    申请人:——
    公开号:US8158623B2
    公开(公告)日:2012-04-17
查看更多